🇺🇸 FDA
Patent

US 10370333

Sulfonamide compounds and uses as TNAP inhibitors

granted A61KA61K31/44A61K31/50

Quick answer

US patent 10370333 (Sulfonamide compounds and uses as TNAP inhibitors) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/44, A61K31/50, A61P, A61P13/12